ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 100 filers reported holding ALBIREO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,974,000 | -25.4% | 600,000 | 0.0% | 0.38% | -9.5% |
| Q3 2021 | $18,720,000 | -11.3% | 600,000 | 0.0% | 0.42% | -2.1% |
| Q2 2021 | $21,108,000 | -0.2% | 600,000 | 0.0% | 0.43% | +14.4% |
| Q1 2021 | $21,150,000 | -19.5% | 600,000 | -14.3% | 0.37% | -33.7% |
| Q4 2020 | $26,257,000 | -7.6% | 700,000 | -17.8% | 0.56% | -18.3% |
| Q3 2020 | $28,411,000 | +114.3% | 851,405 | +70.2% | 0.69% | +86.0% |
| Q2 2020 | $13,255,000 | +37.7% | 500,360 | -14.9% | 0.37% | -8.8% |
| Q1 2020 | $9,628,000 | -15.9% | 588,125 | +30.6% | 0.41% | -7.9% |
| Q4 2019 | $11,444,000 | +27.1% | 450,200 | 0.0% | 0.44% | +22.4% |
| Q3 2019 | $9,004,000 | -37.9% | 450,200 | +0.0% | 0.36% | -38.5% |
| Q2 2019 | $14,508,000 | -9.9% | 450,000 | -10.0% | 0.59% | -10.8% |
| Q1 2019 | $16,105,000 | +31.3% | 500,000 | 0.0% | 0.66% | +44.9% |
| Q4 2018 | $12,265,000 | -25.6% | 500,000 | 0.0% | 0.45% | +5.8% |
| Q3 2018 | $16,480,000 | -7.2% | 500,000 | 0.0% | 0.43% | +13.8% |
| Q2 2018 | $17,750,000 | -0.5% | 500,000 | -8.7% | 0.38% | +69.1% |
| Q1 2018 | $17,843,000 | +132.3% | 547,841 | +82.6% | 0.22% | +92.2% |
| Q4 2017 | $7,680,000 | – | 300,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |